Literature DB >> 7580053

A kinetic study of the coupled iron-ceruloplasmin catalyzed oxidation of ascorbate in the presence of albumin.

R A Løvstad1.   

Abstract

Ascorbate is catalytically oxidized by a couple iron-ceruloplasmin system, the iron ions functioning as a red/ox cycling intermediate between ceruloplasmin and ascorbate. Serum albumin, an iron binding compound, was found to stimulate the ascorbate oxidation rate. It is proposed that ferrous ions react more rapidly with ceruloplasmin when they are bound to albumin. A Km value of 39 microM was estimated for Fe(2+)-albumin. Citrate and urate inhibit the iron-ceruloplasmin-dependent ascorbate oxidation by chelating ferric ions. In the presence of albumin only citrate reduced the oxidation rate, the observation suggesting the following order of iron binding ability: citrate > albumin > urate. Physiological aspects of the results have been discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580053     DOI: 10.1007/BF00141606

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  22 in total

1.  CITRIC ACID AS THE PRINCIPAL SERUM INHIBITOR OF CERULOPLASMIN.

Authors:  S OSAKI; J A MCDERMOTT; E FRIEDEN
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.

Authors:  J M Gutteridge; D A Rowley; E Griffiths; B Halliwell
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

3.  Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.

Authors:  M Grootveld; J D Bell; B Halliwell; O I Aruoma; A Bomford; P J Sadler
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

4.  Role of iron in the oxidase activity of ceruloplasmin.

Authors:  J A McDermott; C T Huber; S Osaki; E Frieden
Journal:  Biochim Biophys Acta       Date:  1968-03-25

5.  The binding of iron to transferrin and to other serum components at different degrees of saturation with iron.

Authors:  C van der Heul; H G van Eijk; W F Wiltink; B Leijnse
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

6.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.

Authors:  S Osaki; D A Johnson; E Frieden
Journal:  J Biol Chem       Date:  1966-06-25       Impact factor: 5.157

7.  Ascorbic acid status in iron-deficiency anaemia.

Authors:  A Jacobs; D Greenman; E Owen; I Cavill
Journal:  J Clin Pathol       Date:  1971-11       Impact factor: 3.411

8.  Transferrin binding of Al3+ and Fe3+.

Authors:  R B Martin; J Savory; S Brown; R L Bertholf; M R Wills
Journal:  Clin Chem       Date:  1987-03       Impact factor: 8.327

9.  Polynuclear iron compounds in human transferrin preparations.

Authors:  S Smit; B Leijnse; A M van der Kraan
Journal:  J Inorg Biochem       Date:  1981-12       Impact factor: 4.155

10.  Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.

Authors:  K J Davies; A Sevanian; S F Muakkassah-Kelly; P Hochstein
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

View more
  3 in total

1.  On the mechanism of citrate inhibition of ceruloplasmin ferroxidase activity.

Authors:  R A Løvstad
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

2.  The nature of heme/iron-induced protein tyrosine nitration.

Authors:  Ka Bian; Zhonghong Gao; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-22       Impact factor: 11.205

Review 3.  The (Bio)Chemistry of Non-Transferrin-Bound Iron.

Authors:  André M N Silva; Maria Rangel
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.